Clinical Trials - Physician

Clinical Trials - Physician

Use the search below to find a complete list of what is available in our state and who you can contact for more information.

Title	Phase	Contact(s)
Treatment with Ipilimumab and Nivolumab for Rare Cancers (DART: Dual Anti-CRLA-4 and Anti-PD-1 Blockade in Rare Tumors) (S1609)		Mary Beth Wilwerding, RN mwilwerding@canceralliance-ne.org Phone 402-991-8070 Fax 402-991-8850
Trial Comparing Paclitaxel, Ifosfamide, and Cisplatin with High-Dose Chemo Using Mobilizing Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin and Etoposide as First Salvage Treatment in Relapsed or Refractory Germ Cell Tumors (A031102)	III	Mary Beth Wilwerding, RN mwilwerding@canceralliance-ne.org Phone 402-991-8070 Fax 402-991-8850
Trial of Salvage Radiotherapy With or Without Enhanced Anti-Androgen Therapy With Apalutamide in Recurrent Prostate Cancer (GU006)	II	Mary Beth Wilwerding, RN mwilwerding@canceralliance-ne.org Phone 402-991-8070 Fax 402-991-8850
Trial to Evaluate the Efficacy and Safety of MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN+) after Neoadjuvant Chemotherapy (S1418)	III	Mary Beth Wilwerding, RN mwilwerding@canceralliance-ne.org Phone 402-991-8070 Fax 402-991-8850
Trial to Evaluate the Efficacy and Safety of Palbociclib + Anti-HER2 Therapy + Endocrine Therapy vs. Anti-HER2 Therapy + Endocrine Therapy after Induction Treatment for Hormone Receptor Positive (HR+)/HER2-Positive Metastatic Breast Cancer (AFT-38)	III	Mary Beth Wilwerding, RN mwilwerding@canceralliance-ne.org Phone 402-991-8070 Fax 402-991-8850

Pages

Become a NOS Member Today!

Platinum Corporate Members

Gold Corporate Members